英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for injection 2ml ampoules (torbay pharmaceuticals - magnesium sulfate heptahydrate - solution for injection - 500mg/1ml

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for injection 5ml ampoules (torbay pharmaceuticals - magnesium sulfate heptahydrate - solution for injection - 500mg/1ml

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for injection 10ml ampoules (torbay pharmaceuticals - magnesium sulfate heptahydrate - solution for injection - 500mg/1ml

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

mygen health pty ltd - ascorbic acid,betacarotene,biotin,calcium citrate tetrahydrate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,iron (ii) glycinate,levomefolate calcium,magnesium citrate,manganese sulfate monohydrate,mecobalamin (co-methylcobalamin),menaquinone 7,nicotinamide,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,riboflavin,selenomethionine,thiamine hydrochloride,ubidecarenone,zinc citrate dihydrate -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

spectrumceuticals pty ltd - magnesium glycinate dihydrate,manganese gluconate,mixed (low-alpha type) tocopherols concentrate,molybdenum trioxide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,zinc citrate dihydrate -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

biomedica nutraceuticals pty ltd - zinc citrate dihydrate, quantity: 38.94 mg (equivalent: zinc, qty 12.5 mg); pyridoxine hydrochloride, quantity: 9.12 mg (equivalent: pyridoxine, qty 7.5 mg); pyridoxal 5-phosphate monohydrate, quantity: 11.76 mg (equivalent: pyridoxine, qty 7.5 mg); magnesium citrate, quantity: 123.46 mg (equivalent: magnesium, qty 20 mg); zinc glycinate, quantity: 62.5 mg (equivalent: zinc, qty 12.5 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; citric acid; silicon dioxide; calcium hydrogen phosphate; glycine; purified water; hypromellose; colloidal anhydrous silica - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; helps maintain/support haemoglobin formation/synthesis ; maintain/support immune system health ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system function ; support healthy emotional/mood balance ; maintain/support reproductive system health ; maintain/support healthy reproductive hormones ; maintain/support wound healing ; maintain/support skin repair/healing/regeneration

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sykes vet (international) pty. ltd. - magnesium sulfate - parenteral liquid/solution/suspension - magnesium sulfate mineral-magnesium active 250.0 g/l - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - grass tetany | magnesium deficiency | hypomagnesaemia | staggers

美国 - 英文 - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

美国 - 英文 - NLM (National Library of Medicine)

general injectables and vaccines, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

美国 - 英文 - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.